Anna Färnert - Infectious Diseases

Author Information

Anna Färnert is an esteemed researcher affiliated with the Division of Infectious Diseases at the Department of Medicine Solna, Karolinska Institutet, located in Stockholm, Sweden. Her work primarily focuses on infectious diseases, and she has made significant contributions through her research, particularly in areas related to malaria, SARS-CoV-2, influenza, and healthcare-associated infections.

Research Contributions

Anna Färnert has been actively involved in numerous studies that have greatly advanced the understanding of infectious diseases. Her research has explored various aspects of malaria, including the immune responses in children in endemic areas and the relapse of malaria infections. She has also contributed to the field of COVID-19 research, investigating viral testing in low suspicion cases and vascular dysfunction caused by erythrocytes in COVID-19 patients. Her work on influenza virus infection has provided insights into immune cell mobilization patterns. Additionally, she has investigated the accuracy of automated algorithms in the surveillance of Clostridioides difficile infections, showcasing her wide-ranging expertise in infectious diseases.

Aliases

Anna Färnert is also known by the aliases A. Färnert and A Färnert. These variations of her name are commonly used in her publications and professional references.

Publication and Citation Metrics

Metric	Value
Total Citation Count	4782
h-index	39
Total Paper Count	145

Publications:

Plasmodium falciparum-Specific Memory B-Cell and Antibody Responses Are Associated With Immunity in Children Living in an Endemic Area of Kenya

DOI: 10.3389/fimmu.2022.799306

Year: 2022

SARS-CoV-2 testing in patients with low COVID-19 suspicion at admission to a tertiary care hospital, Stockholm, Sweden, March to September 2020

DOI: 10.2807/1560-7917.ES.2022.27.7.2100079

Year: 2022

Human influenza virus infection elicits distinct patterns of monocyte and dendritic cell mobilization in blood and the nasopharynx

DOI: 10.1101/2022.01.18.22269508

Year: 2022

The accuracy of fully automated algorithms for surveillance of healthcare-onset Clostridioides difficile infections in hospitalized patients

DOI: 10.1017/ash.2022.32

Year: 2022

Distinct kinetics of antibodies to 111 Plasmodium falciparum proteins identifies markers of recent malaria exposure

DOI: 10.1038/s41467-021-27863-8

Year: 2022

Erythrocytes Induce Vascular Dysfunction in COVID-19

DOI: 10.1016/j.jacbts.2021.12.003

Year: 2022

Systems analysis shows a role of cytophilic antibodies in shaping innate tolerance to malaria.

DOI: 10.1016/j.celrep.2022.110709

Year: 2022

Identification and Characterization of Human Activation-Induced ChAT+CD4+ T Cells

DOI: 10.1101/2021.04.27.441632

Year: 2021

Correction: Profiles of Plasmodium falciparum infections detected by microscopy through the first year of life in Kintampo a high transmission area of Ghana.

DOI: 10.1371/journal.pone.0246773

Year: 2021

Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area

DOI: 10.1093/cid/ciab610

Year: 2021

What is the Future of Infectious Diseases Training?

How is Plasmodium falciparum diagnosed?

How do socio-economic factors influence the spread of infectious diseases?

How are Infectious Diseases Treated?

Who Should Get Regular Health Check-Ups?

How Can Adverse Effects be Minimized?

What is Hepatitis B?

Is There a Vaccine for Ebola?

What Challenges Exist in Implementing Personalized Medicine?

How Can Zoonotic Diseases be Prevented?

Partnered Content Networks

Relevant Topics